Trials / Sponsors / Darell Bigner
Darell Bigner
Academic / Other · 8 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | D2C7-IT + 2141-V11 Combination Post-resection in rGBM Recurrent Glioblastoma IDH Wildtype | Phase 1 | 2025-03-17 |
| Recruiting | Lerapolturev (PVSRIPO) in GBM Recurrent Supratentorial Glioblastoma | Phase 2 | 2024-07-15 |
| Recruiting | D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients Newly Diagnosed MGMT Unmethylated Glioblastoma | Phase 1 / Phase 2 | 2023-09-06 |
| Recruiting | Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma Glioma, Malignant | Phase 1 | 2021-07-09 |
| Withdrawn | PVSRIPO in Combination With Nivolumab in Melanoma Melanoma | Phase 1 | 2020-06-01 |
| Active Not Recruiting | D2C7-IT With Atezolizumab for Recurrent Gliomas Malignant Glioma | Phase 1 | 2020-02-25 |
| Withdrawn | Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma Malignant Glioma | Phase 1 / Phase 2 | 2020-02-01 |
| Completed | D2C7 for Adult Patients With Recurrent Malignant Glioma Malignant Glioma, Brain Tumor, Recurrent | Phase 1 | 2015-05-05 |